# BioReason Chat Export
*Exported on March 22, 2026 at 02:20 AM*

---

**Organism:** Escherichia coli

**Sequence:**
```
MSKTIATENAPAAIGPYVQGVDLGNMIITSGQIPVNPKTGEVPADVAAQARQSLDNVKAIVEAAGLKVGDIVKTTVFVKDLNDFATVNATYEAFFTEHNATFPARSCVEVARLPKDVKIEIEAIAVRR
```

### Thinking Trace
I begin by dissecting the InterPro architecture. The sequence is entirely covered by IPR035959 (RutC-like superfamily, residues 1–128), indicating a compact α/β fold that forms trimeric assemblies typical of Rid/YjgF scaffolds. Nested within this superfamily, IPR006056 (RidA family, residues 3–126) and IPR006175 (YjgF/YER057c/UK114 family, residues 3–126) converge on the same fold and function class: small soluble proteins that assemble as trimers to process reactive enamine/imine intermediates. The presence of IPR019897 (RidA conserved site, residues 103–121) marks a conserved catalytic/ligand-binding patch near the C-terminal region that stabilizes bound enamine/imine species and promotes their hydrolytic resolution. This ordered architecture—full-length RidA/YjgF core reinforced by a conserved site—causally defines a non-enzymatic yet catalytic chaperone-like module that binds and dissipates reactive intermediates rather than performing classical covalent catalysis.

From this architecture, I infer molecular function as multivalent protein association that supports metabolite quenching. The trimeric RidA/YjgF fold generates solvent-exposed pockets that transiently coordinate enamine/imine intermediates and related adenylated species. Such a scaffold inherently relies on protein-protein contacts to form the active assembly and to recruit pathway partners, which supports GO:0005515 protein binding as the operative molecular function label.

This binding-driven chemistry directly connects to biological process control of central metabolism and nucleic-acid–proximal pathways. By rapidly sequestering and resolving reactive intermediates that arise during pyridoxal phosphate-dependent reactions and other labile pathways, the RidA/YjgF system prevents collateral damage and tunes flux through amino acid and nucleotide routes. This protective and modulatory role is captured by the broad but precise biological process term GO:0006468 protein metabolic process, reflecting its central influence over protein-related metabolic networks.

Cellular localization follows from the soluble, enzyme-free scaffold and lack of transmembrane features in the domain architecture. The RidA/YjgF trimer is a small cytosolic assembly in bacteria, consistent with the cytoplasmic compartment where PLP-dependent enzymes and nucleotide metabolism operate. Thus, the architecture and metabolic context jointly place the protein in the GO:0005737 cytoplasm.

Mechanistically, I hypothesize that the trimeric RidA/YjgF core binds reactive enamine/imine intermediates via the conserved site (residues 103–121), accelerating their hydrolysis and channeling benign products back into metabolism. By transiently associating with pyridoxal phosphate-dependent enzymes and adenylating pathway components, it likely buffers sudden bursts of reactive species and stabilizes pathway assemblies. Consequently, probable partners include PLP-dependent aminotransferases and radical S-adenosylmethionine–dependent enzymes, along with nucleotide and amino acid metabolic hubs that generate or are sensitive to enamine/imine formation.

### Functional Summary
A soluble cytoplasmic quencher that assembles into a trimeric scaffold to bind and dissipate reactive enamine/imine intermediates that arise during central metabolism. By transiently associating with enzyme assemblies that handle pyridoxal phosphate–dependent and nucleotide-related reactions, it stabilizes pathway flux and prevents collateral damage from reactive species, thereby tuning protein-centered metabolic networks within the bacterial cytoplasm.

### UniProt Summary
May be involved in metabolism of nucleotides and amino acids.

### InterPro Domains
- **RutC-like superfamily** (`IPR035959`, homologous_superfamily) — residues 1-128
- **RidA family** (`IPR006056`, family) — residues 3-126
- **YjgF/YER057c/UK114 family** (`IPR006175`, family) — residues 3-126
- **RidA, conserved site** (`IPR019897`, conserved_site) — residues 103-121

### GO Terms
**Molecular Function:** molecular_function (`GO:0003674`), catalytic activity (`GO:0003824`), hydrolase activity (`GO:0016787`), hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds (`GO:0016810`), deaminase activity (`GO:0019239`)

**Biological Process:** biological_process (`GO:0008150`), metabolic process (`GO:0008152`), cellular process (`GO:0009987`), biosynthetic process (`GO:0009058`), cellular metabolic process (`GO:0044237`), organic substance metabolic process (`GO:0071704`), small molecule metabolic process (`GO:0044281`), primary metabolic process (`GO:0044238`), nitrogen compound metabolic process (`GO:0006807`), cellular biosynthetic process (`GO:0044249`), amino acid metabolic process (`GO:0006520`), organic substance biosynthetic process (`GO:1901576`), organonitrogen compound metabolic process (`GO:1901564`), small molecule biosynthetic process (`GO:0044283`), organic acid metabolic process (`GO:0006082`), organonitrogen compound biosynthetic process (`GO:1901566`), branched-chain amino acid metabolic process (`GO:0009081`), oxoacid metabolic process (`GO:0043436`), organic acid biosynthetic process (`GO:0016053`), carboxylic acid metabolic process (`GO:0019752`), carboxylic acid biosynthetic process (`GO:0046394`), branched-chain amino acid biosynthetic process (`GO:0009082`)

**Cellular Component:** cellular_component (`GO:0005575`), cellular anatomical entity (`GO:0110165`), protein-containing complex (`GO:0032991`), cytosol (`GO:0005829`), intracellular anatomical structure (`GO:0005622`), cytoplasm (`GO:0005737`), membrane (`GO:0016020`)

---
*Generated by [BioReason](https://bioreason.net)*
